Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (Q33488674)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q33113704)
(Q56335956)
(P304) 1537-1545
(P407) (Q1860)
(P433) 7
(P478) 13
(P577) Saturday, July 1, 1995
(P921) (Q18936)
(Q418560)
(P1433) (Q400292)
(P1476) "Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group" (language: en)
(P2093) A Santoro
H Mouridsen
J Verweij
W Steward
R Somers
J Buesa
P Casali
D Spooner
E Rankin
other details
description scientific article

External Links